MEDraysintell and NucAdvisor Join Forces to Expand Their Activities in Nuclear Medicine Consulting Services
MEDraysintell and NucAdvisor, an independent nuclear consulting company, subsidiary of Soletanche Freyssinet (VINCI Group), France, today announced the integration of the MEDraysintell business into NucAdvisor, including the brand and copyright assets. NucAdvisor will now assume responsibility for... - September 06, 2024
MEDraysintell Publishes the 9th Edition of Its Nuclear Medicine Report & Directory
A set of three volumes (3,500 pages) with a description of 970 products, together with a comprehensive profile of 380 companies active around the world in the radiopharmaceutical industry. - September 16, 2022
MEDraysintell Publishes the 8th Edition of Its Nuclear Medicine Report & Directory
A set of three volumes (3,100 pages) with a description of 870 products, together with a comprehensive profile of 340 companies active around the world in the radiopharmaceutical industry. - September 16, 2021
MEDraysintell Publishes Its New Proton Therapy World Report & Directory, Edition 2021
Proton therapy market headwinds: demand down, supply up, but increasing awareness. - March 06, 2021
MEDraysintell Welcomes Jean-Luc Vanderheyden as Advisor
Jean-Luc Vanderheyden joins MEDraysintell as Advisor and brings his extended experience (35 years) in the field of nuclear medicine. Jean-Luc is a Doctor of Pharmacy and PhD Analytical Chemist (Université Libre de Bruxelles and University of Cincinnati), with a strong expertise in... - September 05, 2020
MEDraysintell Publishes Its New Nuclear Medicine Report and Directory
A set of three volumes (2,900 pages) with a description of about 830 products and nearly 320 companies active in nuclear medicine. - September 02, 2020
MEDraysintell Releases the Most Unique Cyclotron Directory
A 450-page report which provides an extensive review of all cyclotrons installed worldwide. - March 11, 2020
MEDraysintell Releases Its New Early Stage Radiopharmaceuticals Report
In addition to its original Nuclear Medicine Report - July 12, 2019
MEDraysintell Publishes Its Sixth Edition of the Proton Therapy World Report & Directory
What to Expect from the Proton Therapy Market in 2019-2020? - February 21, 2019
MEDraysintell Anticipates Increasing M&A Activities in Nuclear Medicine
Some US$10 billion in M&A transactions during the past four years. - November 08, 2018
MEDraysintell to Showcase Its Reports at EANM in Düsseldorf
MEDraysintell will be present on The Belgian Pavilion booth-14. - October 04, 2018
MEDraysintell Releases the Fifth Edition of Its Nuclear Medicine Report and Directory
New radiotheranostics under development might lead to much stronger market figures than expected in coming years. - July 18, 2018
Serge Goossens Joins MEDraysintell as Co-Author & Advisor
A new report and directory about radioactive material transport and handling under preparation. - June 20, 2018
MEDraysintell Releases a New Report Covering the Most Promising Radiopharmaceuticals
Most promising radiopharmaceuticals on the market by 2024-2026 - February 03, 2018
MEDraysintell Releases Its New Proton Therapy World Market Report & Directory Edition 2018
The top three vendors share now 70% of the PT market in 2017 valued at US$ 0.9 billion. Several companies are expected to enter the market for the first time in the coming years with their own PT systems. - January 19, 2018
MEDraysintell Downgrades Its Proton Therapy Market Projection
In light of several factors summarized below, MEDraysintell is downgrading its proton therapy market projection from 1,200 proton therapy treatment rooms that were expected to be operational in 2030 to 900. This still represents a 12% annual growth from 2017 to 2030 and the need to open an average... - December 02, 2017
MEDraysintell Will Display Its Series of Market Reports at EANM Congress in Vienna
Need to understand future and economics of Nuclear Medicine? Looking for experts in this field? Trying to appreciate the potential of this new technology? - October 11, 2017
MEDraysintell Releases Its First Nuclear Medicine Market Essentials Report
A condensed report, with over 40 tables and figures, providing the most accurate and up-to-date information related to the nuclear medicine industry. - January 20, 2017
Brachytherapy Market Driven by New Technologies and New Indications
The global market for brachytherapy reached US$ 680 million in 2013, and the trend is toward a growth driven by new technologies (electronic brachytherapy, microspheres), new indications for LDR (lung, liver) and new markets (Asia, South America). - November 14, 2014